191 related articles for article (PubMed ID: 16388852)
21. A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital.
Blairon L; De Gheldre Y; Delaere B; Sonet A; Bosly A; Glupczynski Y
Clin Microbiol Infect; 2006 Jun; 12(6):527-32. PubMed ID: 16700700
[TBL] [Abstract][Full Text] [Related]
22. Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?
Dubberke ER; Hollands JM; Georgantopoulos P; Augustin K; DiPersio JF; Mundy LM; Khoury HJ
Bone Marrow Transplant; 2006 Dec; 38(12):813-9. PubMed ID: 17057724
[TBL] [Abstract][Full Text] [Related]
23. Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study.
Venditti M; Falcone M; Micozzi A; Carfagna P; Taglietti F; Serra PF; Martino P
Haematologica; 2003 Aug; 88(8):923-30. PubMed ID: 12935981
[TBL] [Abstract][Full Text] [Related]
24. [Emergency of vancomycin-resistant Enterococcus infections in a teaching hospital in Chile].
Fica A; Jemenao MI; Bilbao P; Ruiz G; Sakurada A; Pérez de Arce E; Zúñiga I; Gompertz M
Rev Chilena Infectol; 2007 Dec; 24(6):462-71. PubMed ID: 18180821
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with mortality in bacteremic patients with hematologic malignancies.
Tumbarello M; Spanu T; Caira M; Trecarichi EM; Laurenti L; Montuori E; Fianchi L; Leone F; Fadda G; Cauda R; Pagano L
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):320-6. PubMed ID: 19345033
[TBL] [Abstract][Full Text] [Related]
26. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
Mohr JF; Friedrich LV; Yankelev S; Lamp KC
Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
Mikulska M; Del Bono V; Prinapori R; Boni L; Raiola AM; Gualandi F; Van Lint MT; Dominietto A; Lamparelli T; Cappellano P; Bacigalupo A; Viscoli C
Transpl Infect Dis; 2010 Dec; 12(6):505-12. PubMed ID: 20636482
[TBL] [Abstract][Full Text] [Related]
28. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
[TBL] [Abstract][Full Text] [Related]
29. Enterococcal meningitis: a clinical study of 39 cases and review of the literature.
Pintado V; Cabellos C; Moreno S; Meseguer MA; Ayats J; Viladrich PF
Medicine (Baltimore); 2003 Sep; 82(5):346-64. PubMed ID: 14530784
[TBL] [Abstract][Full Text] [Related]
30. Bacteraemia in febrile neutropenic cancer patients.
Klastersky J; Ameye L; Maertens J; Georgala A; Muanza F; Aoun M; Ferrant A; Rapoport B; Rolston K; Paesmans M
Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S51-9. PubMed ID: 17689933
[TBL] [Abstract][Full Text] [Related]
31. Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk.
Worth LJ; Thursky KA; Seymour JF; Slavin MA
Eur J Haematol; 2007 Sep; 79(3):226-33. PubMed ID: 17655696
[TBL] [Abstract][Full Text] [Related]
32. Obesity and smoking are factors associated with poor prognosis in patients with bacteraemia.
Huttunen R; Laine J; Lumio J; Vuento R; Syrjänen J
BMC Infect Dis; 2007 Mar; 7():13. PubMed ID: 17349033
[TBL] [Abstract][Full Text] [Related]
33. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Clin Microbiol Infect; 2005 May; 11(5):415-8. PubMed ID: 15819873
[TBL] [Abstract][Full Text] [Related]
34. [Enterococcus spp. colonized in the gastrointestinal tract of patients in hemato-oncology and intensive care units and their resistance profiles to vancomycin].
Menteş O; Balci I
Mikrobiyol Bul; 2007 Oct; 41(4):585-9. PubMed ID: 18173078
[TBL] [Abstract][Full Text] [Related]
35. Unusual increase of vancomycin-resistant Enterococcus faecium but not Enterococcus faecalis at a university hospital in Taiwan.
Chiang PC; Wu TL; Su JY; Huang YC; Chiu YP; Chia JH; Kuo AJ; Su LH
Chang Gung Med J; 2007; 30(6):493-503. PubMed ID: 18350732
[TBL] [Abstract][Full Text] [Related]
36. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW
J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248
[TBL] [Abstract][Full Text] [Related]
37. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis.
Cherif H; Kronvall G; Björkholm M; Kalin M
Hematol J; 2003; 4(6):420-6. PubMed ID: 14671614
[TBL] [Abstract][Full Text] [Related]
38. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L
J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
[TBL] [Abstract][Full Text] [Related]
39. [Vancomycin and high-level aminoglycoside resistant Enterococcus carriage and the risk factors related to resistance in hospitalized patients].
Yildirim M; Sencan I; Ozdemir D; Oksüz S; Yilmaz Z; Sahin I
Mikrobiyol Bul; 2007 Apr; 41(2):271-7. PubMed ID: 17682714
[TBL] [Abstract][Full Text] [Related]
40. Risk factors and outcomes associated with non-Enterococcus faecalis, non-Enterococcus faecium enterococcal bacteremia.
de Perio MA; Yarnold PR; Warren J; Noskin GA
Infect Control Hosp Epidemiol; 2006 Jan; 27(1):28-33. PubMed ID: 16418983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
